Circulating levels of transforming growth Factor-β1 and lymphokines among children with hemolytic uremic syndrome
- 31 January 2000
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 35 (1) , 29-34
- https://doi.org/10.1016/s0272-6386(00)70297-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndromeThe Pediatric Infectious Disease Journal, 1998
- Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpuraPediatric Nephrology, 1995
- Escherichia coliO157:H7 and the Hemolytic–Uremic SyndromeNew England Journal of Medicine, 1995
- Tumor necrosis factor concentrations in hemolytic uremic syndrome patients and children with bloody diarrhea in ArgentinaThe Pediatric Infectious Disease Journal, 1995
- A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome.Journal of Clinical Investigation, 1993
- Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndromeBlood, 1992
- Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhoodKidney International, 1992
- Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988The Journal of Pediatrics, 1991
- Verotoxin Receptor Glycolipid in Human Renal TissueNephron, 1989
- The Association Between Idiopathic Hemolytic Uremic Syndrome and Infection by Verotoxin-Producing Escherichia coliThe Journal of Infectious Diseases, 1985